AAAAAA

   
Results: 1-15 |
Results: 15
NUMBER OF CD34-DOSE CHEMOTHERAPY( CELLS INFUSED IS RELATED TO COMPLICATIONS AND MORTALITY OF HIGH)
Authors: YUBERO A SAENZ A MAYORDOMO JI CAJAL R ALONSO M BUESO P HERRAEZ J GARCIAPRATS MD ESCUDERO P ISLA D TRES A
Citation: A. Yubero et al., NUMBER OF CD34-DOSE CHEMOTHERAPY( CELLS INFUSED IS RELATED TO COMPLICATIONS AND MORTALITY OF HIGH), European journal of cancer, 34, 1998, pp. 182-182
PHASE-II TRIAL OF FIRST-LINE HIGH-DOSE IFOSFAMIDE IN ADVANCED SOFT-TISSUE SARCOMAS OF THE ADULT - A STUDY OF THE SPANISH GROUP FOR RESEARCHON SARCOMAS (GEIS)
Authors: BUESA JM LOPEZPOUSA A MARTIN J ANTON A DELMURO JG BELLMUNT J ARRANZ F VALENTI V ESCUDERO P MENENDEZ D CASADO A POVEDA A
Citation: Jm. Buesa et al., PHASE-II TRIAL OF FIRST-LINE HIGH-DOSE IFOSFAMIDE IN ADVANCED SOFT-TISSUE SARCOMAS OF THE ADULT - A STUDY OF THE SPANISH GROUP FOR RESEARCHON SARCOMAS (GEIS), Annals of oncology, 9(8), 1998, pp. 871-876
ACTIVITY OF DOXORUBICIN AFTER HIGH-DOSE IFOSFAMIDE IN ADULT PATIENTS WITH ADVANCED SOFT-TISSUE SARCOMA - A STUDY OF THE SPANISH GROUP FOR RESEARCH ON SARCOMAS (GEIS)
Authors: BUESA JM FRA J ANTON A LOPEZPOUSA A MARTIN J DELMURO JG ESCUDERO P CASADO A POVEDA A
Citation: Jm. Buesa et al., ACTIVITY OF DOXORUBICIN AFTER HIGH-DOSE IFOSFAMIDE IN ADULT PATIENTS WITH ADVANCED SOFT-TISSUE SARCOMA - A STUDY OF THE SPANISH GROUP FOR RESEARCH ON SARCOMAS (GEIS), Annals of oncology, 9(7), 1998, pp. 783-785
RISK-FACTORS AND REVERSIBILITY OF NEUROTOXICITY INDUCED BY HIGH-DOSE PACLITAXEL
Authors: MAYORDOMO JI YUBERO A INIGUEZ C LARRODE P ISLA D ESCUDERO P CAJAL R ALONSO M SAENZ A TRES A
Citation: Ji. Mayordomo et al., RISK-FACTORS AND REVERSIBILITY OF NEUROTOXICITY INDUCED BY HIGH-DOSE PACLITAXEL, European journal of cancer, 33, 1997, pp. 73-73
NUMBER OF CD34-DOSE CHEMOTHERAPY(CELLS INFUSED AND DURATION OF APLASIA AFTER HIGH)
Authors: HERRAEZ J YUBERO A PALOMERA L MORENO JA MAYORDOMO JI CAJAL R ALONSO M BUESO P ESCUDERO P TRES A
Citation: J. Herraez et al., NUMBER OF CD34-DOSE CHEMOTHERAPY(CELLS INFUSED AND DURATION OF APLASIA AFTER HIGH), European journal of cancer, 33, 1997, pp. 407-407
DOSE-ESCALATION OF PACLITAXEL IN COMBINATION WITH CYCLOPHOSPHAMIDE, THIOTEPA AND CARBOPLATIN WITH STEM-CELL RESCUE
Authors: YUBERO A MAJORDOMO JI CAJAL R INIGUEZ C LARRODE P HERRAEZ J ESCUDERO P SAENZ A TRES A
Citation: A. Yubero et al., DOSE-ESCALATION OF PACLITAXEL IN COMBINATION WITH CYCLOPHOSPHAMIDE, THIOTEPA AND CARBOPLATIN WITH STEM-CELL RESCUE, European journal of cancer, 33, 1997, pp. 408-408
COMPARISON OF 2 SYSTEMS FOR STEM-CELL MOVILIZATION (G-CSF + - CHEMOTHERAPY) IN BREAST-CANCER PATIENTS/
Authors: ISLA D HERRAEZ J ALONSO M MAYORDOMO JI CAJAL R BUESO P ESCUDERO P MORENO JA PALOMERA L TRES A
Citation: D. Isla et al., COMPARISON OF 2 SYSTEMS FOR STEM-CELL MOVILIZATION (G-CSF + - CHEMOTHERAPY) IN BREAST-CANCER PATIENTS/, European journal of cancer, 33, 1997, pp. 409-409
INCIDENCE OF DELAYED INFECTIONS AFTER HIGH-DOSE CHEMOTHERAPY WITH PERIPHERAL-BLOOD STEM-CELL SUPPORT
Authors: YUBERO A ISLA D MAYORDOMO JI CAJAL R ALONSO M BUESO P HERRAEZ J ESCUDERO P MORENO JA TRES A
Citation: A. Yubero et al., INCIDENCE OF DELAYED INFECTIONS AFTER HIGH-DOSE CHEMOTHERAPY WITH PERIPHERAL-BLOOD STEM-CELL SUPPORT, European journal of cancer, 33, 1997, pp. 413-413
ECONOMIC COSTS OF HIGH-DOSE CHEMOTHERAPY WITH PERIPHERAL-BLOOD STEM-CELL RESCUE
Authors: ISLA D ASTIER P MAYORDOMO JI ALONSO M CAJAL R YUBERO A SAENZ A ESCUDERO P ABAD A TRES A
Citation: D. Isla et al., ECONOMIC COSTS OF HIGH-DOSE CHEMOTHERAPY WITH PERIPHERAL-BLOOD STEM-CELL RESCUE, European journal of cancer, 33, 1997, pp. 418-418
LONG-TERM RESULTS OF CHEMOTHERAPY IN ADVANCED THYROID-CARCINOMA
Authors: BUESO P ISLA D MAYORDOMO JI ALONSO M HERRAEZ J CAJAL R YUBERO A ESCUDERO P SAENZ A TRES A
Citation: P. Bueso et al., LONG-TERM RESULTS OF CHEMOTHERAPY IN ADVANCED THYROID-CARCINOMA, European journal of cancer, 33, 1997, pp. 865-865
COMBINED THERAPY FOR ADVANCED THYMOMA
Authors: ISLA D HERRAEZ J BASCON N YUBERO A CAJAL R BUESO P SAENZ A ESCUDERO P ESCO R TRES A
Citation: D. Isla et al., COMBINED THERAPY FOR ADVANCED THYMOMA, European journal of cancer, 33, 1997, pp. 1236-1236
ORAL TEGAFUR AND FOLINIC ACID FOR THE TREATMENT OF ADVANCED COLORECTAL-CANCER
Authors: ISLA MD MAYORDOMO JI CAJAL R SAENZ A ESCUDERO P TRES A
Citation: Md. Isla et al., ORAL TEGAFUR AND FOLINIC ACID FOR THE TREATMENT OF ADVANCED COLORECTAL-CANCER, European journal of cancer, 33(1), 1997, pp. 166-167
PHASE-II TRIAL OF ORAL TEGAFUR AND FOLINIC ACID WITH MITOXANTRONE AS FIRST-LINE REGIMEN IN PATIENTS WITH METASTATIC BREAST-CANCER
Authors: ALONSO V SANTANDER C FLORIAN J ALONSO M ISLA MD ESCUDERO P SAENZ A TRES A
Citation: V. Alonso et al., PHASE-II TRIAL OF ORAL TEGAFUR AND FOLINIC ACID WITH MITOXANTRONE AS FIRST-LINE REGIMEN IN PATIENTS WITH METASTATIC BREAST-CANCER, Tumori, 82(1), 1996, pp. 61-64
A PILOT-STUDY OF ADJUVANT POSTOPERATIVE CHEMOHORMONAL THERAPY WITH 5-FLUOROURACIL, DOXORUBICIN, CYCLOPHOSPHAMIDE, VINDESINE AND TAMOXIFEN FOR RESECTABLE BREAST-CANCER
Authors: ALONSO V FLORIAN J ALONSO M CAJAL R YUBERO A ISLA MD ESCUDERO P SAENZ A MAYORDOMO JI TRES A
Citation: V. Alonso et al., A PILOT-STUDY OF ADJUVANT POSTOPERATIVE CHEMOHORMONAL THERAPY WITH 5-FLUOROURACIL, DOXORUBICIN, CYCLOPHOSPHAMIDE, VINDESINE AND TAMOXIFEN FOR RESECTABLE BREAST-CANCER, European journal of cancer, 31A, 1995, pp. 75-75
COMBINED CHEMOTHERAPY AND RADIOTHERAPY WI TH OR WITHOUT SURGERY FOR ESOPHAGUS NONMETASTATIC CELL-CARCINOMA
Authors: ISLA MD SAENZ A TRES A ESCUDERO P JARA C ESCO R GONZALEZ M
Citation: Md. Isla et al., COMBINED CHEMOTHERAPY AND RADIOTHERAPY WI TH OR WITHOUT SURGERY FOR ESOPHAGUS NONMETASTATIC CELL-CARCINOMA, Revista espanola de enfermedades digestivas, 84(6), 1993, pp. 361-365
Risultati: 1-15 |